cyproterone acetate, ethinyl estradiol drug combination has been researched along with c-peptide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balint-Perić, L; Prelević, GM; Trpković, D; Würzburger, MI | 1 |
| Gaspard, UJ; Humblet, DM; Jaminet, CB; Jandrain, BJ; Lefèbvre, PJ; Scheen, AJ | 1 |
2 other study(ies) available for cyproterone acetate, ethinyl estradiol drug combination and c-peptide
| Article | Year |
|---|---|
Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on lipid and carbohydrate metabolism in patients with polycystic ovary syndrome.
Topics: Adolescent; Adult; Androgen Antagonists; Apolipoproteins; C-Peptide; Carbohydrate Metabolism; Cholesterol; Cyproterone; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Insulin; Lipid Metabolism; Male; Polycystic Ovary Syndrome; Triglycerides | 1990 |
Effects of a 1-year treatment with a low-dose combined oral contraceptive containing ethinyl estradiol and cyproterone acetate on glucose and insulin metabolism.
Topics: Adult; C-Peptide; Contraceptives, Oral, Combined; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Metabolic Clearance Rate | 1993 |